Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00306384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-Term, Open-Label Extension Study to Investigate the Long-Term Safety of SYR110322 (SYR-322) in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety of alogliptin, once daily (QD), following participation in 1 of 7 controlled studies in patients with type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT00306384
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 3,323 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Nov 2011 (Actual)
- Completion
- Nov 2011 (Actual)
- Last update posted
- Mar 22, 2013
2006 – 2011
United States locations
- U.S. sites
- 62
- U.S. states
- 27
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Artesia | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Mission Viejo | California | — | — |
| Not listed | Northridge | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Norwalk | Connecticut | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Longwood | Florida | — | — |
| Not listed | New Port Richie | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Ocoee | Florida | — | — |
| Not listed | Saint Cloud | Florida | — | — |
| Not listed | Lawrenceville | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Idaho Falls | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Elkhart | Indiana | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Lafayette | Indiana | — | — |
| Not listed | Erlanger | Kentucky | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Sudbury | Massachusetts | — | — |
| Not listed | Chesterfield | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Pinehurst | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnatti | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Lansdale | Pennsylvania | — | — |
| Not listed | West Grove | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Cookeville | Tennessee | — | — |
| Not listed | Milan | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Temple | Texas | — | — |
| Not listed | Texarkana | Texas | — | — |
| Not listed | Burlington | Vermont | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00306384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2013 · Synced Nov 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00306384 live on ClinicalTrials.gov.